Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

64% of UK Consumers Want to Use Agentic AI for Shopping, According to New Research from Commerce and PayPal

64% of UK Consumers Want to Use Agentic AI for Shopping, According to New Research from Commerce and PayPal

Commerce and PayPal released a research study revealing 64% of UK consumers are interested in using agentic AI tools for shopping, which assist in product research, comparison, and purchasing. While adoption is nascent, most consumers desire AI to facilitate better deals and discounts but prefer to retain control over purchase decisions. The study …

VisionWave Unveils Combat-Ready TALON™ and D-FLY™ Autonomous Drone Platforms at Eurosatory 2026, Expanding STRATUM™ Battlefield Autonomy Ecosystem

VisionWave Unveils Combat-Ready TALON™ and D-FLY™ Autonomous Drone Platforms at Eurosatory 2026, Expanding STRATUM™ Battlefield Autonomy Ecosystem

VisionWave Holdings, Inc. introduced two new autonomous drone platforms, TALON™ Tactical Autonomous Aerial System and D-FLY™ Autonomous Intercept Platform, at Eurosatory 2026. These platforms expand VisionWave's STRATUM™ battlefield autonomy ecosystem, demonstrating integrated AI-driven autonomous capabilities for ISR, counter-UAS, communications r…

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer

Revolution Medicines has announced the commencement of patient treatment in RASolute 305, a global Phase 3 randomized trial evaluating zoldonrasib combined with standard chemotherapy as a first-line treatment in metastatic RAS G12D pancreatic ductal adenocarcinoma (PDAC). Building on previous positive data with their RAS(ON) inhibitors, this trial …

Airship AI Secures Seven Figure Follow-On Contract Award with Fortune 100 Transportation & E-Commerce Company

Airship AI Secures Seven Figure Follow-On Contract Award with Fortune 100 Transportation & E-Commerce Company

Airship AI Holdings announced a significant one-year contract extension worth $1.9 million with an existing Fortune 100 transportation and e-commerce client for maintenance and sustainment of its Acropolis Enterprise Video and Data Management platform. The company also received additional smaller orders totaling $1.4 million, enhancing its recurrin…

Two-Thirds of Consumers Are Ready to Try Agentic Shopping, but Many Demand Human Approval Before AI Can Buy

Two-Thirds of Consumers Are Ready to Try Agentic Shopping, but Many Demand Human Approval Before AI Can Buy

Commerce (Nasdaq: CMRC) released a research study revealing that two-thirds of consumers across the US, UK, and Australia are interested in trying AI-powered agentic shopping tools that assist with product discovery, comparison, and purchasing. While enthusiasm is high, consumers emphasize the need for transparency, security, and human approval in …

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

INmune Bio secured written alignment from the UK MHRA on its development and regulatory strategy for CORDStrom™ (Ebstrocel™) targeting Recessive Dystrophic Epidermolysis Bullosa (RDEB). The guidance clarifies manufacturing, safety, and clinical evidence requirements and supports a 2026 conditional marketing authorization submission in the UK, with …

Integra LifeSciences Announces Key Executive Appointments

Integra LifeSciences Announces Key Executive Appointments

Integra LifeSciences Corporation Holdings announced a series of leadership changes within its commercial organization, including new appointments and promotions aimed at enhancing customer focus, accelerating execution, and supporting the company’s long-term growth strategy. These changes involve executives leading key divisions such as Tissue Reco…

Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer

Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer

Provident Bank appointed Adriano Duarte as Executive Vice President and Chief Financial Officer, effective July 1, 2026. Duarte, with over 30 years of banking experience, previously served as EVP and Chief Accounting Officer and will lead key financial functions to support growth and financial performance at Provident Bank and its parent company, P…

Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

Phathom Pharmaceuticals announced early completion of patient enrollment for its Phase 2 pHalcon-EoE-201 clinical trial assessing VOQUEZNA® (vonoprazan) as a potential treatment for eosinophilic esophagitis (EoE). The double-blind, placebo-controlled study enrolled 95 adult patients across 41 U.S. sites, with topline results expected in Q4 2026. Po…

Edible Garden Secures Up to $6.3 Million in Local Development Incentives to Support Webster City Clean Nutrition Manufacturing Hub

Edible Garden Secures Up to $6.3 Million in Local Development Incentives to Support Webster City Clean Nutrition Manufacturing Hub

Edible Garden AG Incorporated announced a development agreement securing up to $6.3 million in tax increment financing incentives from Webster City to support the redevelopment and expansion of its Prairie Hills facility into a large-scale ready-to-drink (RTD) beverage production hub. This investment builds upon a previous $2.66 million incentive f…

Quantum Cyber Unveils Quantum Station: A Battlefield Operating System for Multi-Domain Autonomous Warfare

Quantum Cyber Unveils Quantum Station: A Battlefield Operating System for Multi-Domain Autonomous Warfare

Quantum Cyber N.V. (Nasdaq: QUCY) unveiled Quantum Station, a rugged, integrated battlefield operating system designed to unify drone command-and-control across air, land, and sea domains. The system consolidates hardware, software, and communication layers into a portable, secure platform that supports multiple drone protocols and operates in cont…

Robert Brackenbury Appointed to Athene Board of Directors

Robert Brackenbury Appointed to Athene Board of Directors

Athene Holding Ltd., a major player in the retirement services industry, announced the appointment of Robert Brackenbury to its Board of Directors. Brackenbury brings extensive experience managing large public pension systems and investment assets, enhancing Athene's capabilities in delivering reliable retirement income solutions.

Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)

Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)

Zevra Therapeutics announced the publication of positive Phase 2/3 pediatric substudy data showing that MIPLYFFA (arimoclomol), used alongside miglustat, is generally safe and well tolerated in infants with Niemann-Pick disease type C (NPC). The study provides preliminary evidence supporting earlier treatment initiation in this severe rare disease.…

Plus Therapeutics to Provide Business Update Call on June 30, 2026

Plus Therapeutics to Provide Business Update Call on June 30, 2026

Plus Therapeutics announced a business update call scheduled for June 30, 2026, focusing on the launch of its CNSide cerebrospinal fluid diagnostic platform, ongoing development of its lead drug candidate Reyobiq, and integrated artificial intelligence strategies targeting central nervous system cancers. Management highlighted progress across diagn…

Roadzen's drivebuddyAI Lands $5.3 Million Agreement to Equip 3,600 Electric Buses and Trucks in India with AI Safety

Roadzen's drivebuddyAI Lands $5.3 Million Agreement to Equip 3,600 Electric Buses and Trucks in India with AI Safety

Roadzen Inc. has announced a $5.3 million agreement to equip 3,600 electric buses and trucks operated by a leading Indian fleet with its drivebuddyAI platform. The deployment spans public transportation, logistics, seaport, mining, and industrial sectors. This follows a recent $ multi-million contract awarded to deploy the AI-powered safety and dri…

Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market

Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market

Trinity Biotech plc has launched a new subsidiary, Trinovium, to focus on advanced liquid cooling solutions for AI and high-performance computing data centers. Utilizing its existing manufacturing capacity and expertise in ultra-high-purity fluids, the company aims to address the increasing need for reliable liquid cooling systems driven by escalat…

Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

Boundless Bio and Serapha Bio announce an all-stock merger, combining to operate as Serapha Bio, Inc. The combined company aims to advance SERP-01, an investigational base editing therapy targeting Alpha-1 Antitrypsin Deficiency (AATD), addressing both lung and liver manifestations. The deal is supported by a $230 million private placement led by t…

Fossil Group, Inc. Announces Inclusion in Russell 2000® Index

Fossil Group, Inc. Announces Inclusion in Russell 2000® Index

Fossil Group, Inc. announced its inclusion in the Russell 2000 Index effective June 26, 2026. The company expects this inclusion to enhance visibility among investors and support its ongoing turnaround and long-term growth objectives. Fossil Group is a global designer and marketer of lifestyle accessories including watches and jewelry under various…

Aeluma Names Brendan Moran Vice President of Engineering

Aeluma Names Brendan Moran Vice President of Engineering

Aeluma, a NASDAQ-listed semiconductor company, has appointed Dr. Brendan Moran as Vice President of Engineering to lead the commercialization and manufacturing transition of its compound semiconductor products. Dr. Moran brings extensive experience from Lumileds and will help scale Aeluma's photonics technologies for multiple high-growth markets in…

Baker Hughes Awarded Significant Long-Term Service Agreement with ANOH Gas Processing Company for Gas Plant in Nigeria

Baker Hughes Awarded Significant Long-Term Service Agreement with ANOH Gas Processing Company for Gas Plant in Nigeria

Baker Hughes has been awarded a significant long-term service agreement with ANOH Gas Processing Company to provide parts, repair services, engineering advisory, and digital monitoring for critical turbomachinery at the ANOH Gas Processing Plant in Nigeria. This agreement reinforces Baker Hughes' role as a lifecycle solutions provider and supports …